Company Profile

Nanova Inc
Profile last edited on: 12/29/17      CAGE: 4SMQ5      UEI: Z59LCLFULK75

Business Identifier: Nanotech-based line of dental consumables
Year Founded
2007
First Award
2009
Latest Award
2019
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3806 Mojave Court
Columbia, MO 65202
   (573) 234-6451
   nanovainc@gmail.com
   www.nanovabio.com/
Location: Single
Congr. District: 04
County: Boone

Public Profile

Nanova Inc. is a high tech company that designs, patents, and sells medical and non-medical devices and sensors in orthopedic, dental, cardiovascular, and other medical and non-medical niche markets using nanotechnology. Nanova Inc specializes in Dental Materials and Devices, Orthopedic Devices, Cardiovascular Devices and Sensors. Nanova employs core team members in the fields of nanotechnology, sensors, medical science, and food safety allowing the firm to the ability to develop a series of innovative and high quality products that will impact various niche markets based on their understanding of the needs of doctors, dentists, medical personal and their patients. Nanova is interested in forming collaborative relationship and/or strategic relationship with researchers and industry leaders who have common interests with Nanova. The Q-SERS substrate, designed to generate Surface-Enhanced Raman Scattering (SERS) signals when used with a Raman Spectroscope, is capable of detecting trace amount of chemical and biochemical agents. Q-SERS substrates can provide high enhancement of Raman signals, reliable and reproducible testing results, and long shelf life. The superior performance of the Q-SERS substrate makes it ideal for analytical chemistry, agricultural and food safety, water safety, pharmaceutical, medical, forensic science, and many other applications.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2019 2 NIH $4,617,195
Project Title: Improved Long-Term Biocompatibility of Coronary Stents by Plasma Coating Process
2012 2 NIH $1,691,794
Project Title: Development Of A Miniature Plasma Brush For Dental Clinical Applicationsy
2010 2 NIH $509,669
Project Title: Calcium Phosphate Bone Cement Nanocomposites

Key People / Management

  Hao Li -- President

  Meng Chen

  Kenneth L Lambert

Company News

There are no news available.